Anita Müller

Mrs. Anita Müller


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023
Verified
Book Chapter
Closed access
PDF file
CMClément Métais
Clément Métais
MOMarie Oger
Marie Oger
Guillaume BrocGuillaume Broc
Guillaume Broc
SDStéphanie Vouteau Douet
Stéphanie Vouteau Douet
AMAnita Müller
Anita Müller
CMCharles Martin-Krumm
Charles Martin-Krumm

15 November 2024 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
AMAnita Müller
Anita Müller
SDSylvie Dolbeault
Sylvie Dolbeault
SPSophie Piperno-Neumann
Sophie Piperno-Neumann
MCMorgane Clerc
Morgane Clerc
PJPaulin Jarry
Paulin Jarry
ABAnne Bredart
Anne Bredart
Quality of life (QoL) in patients undergoing surveillance for uveal melanoma (UM) can be affected by psychological sequelae. Fear of cancer recurrence (FCR) may be acute especially when prognostication indicates an increased risk of metastatic recurrence. Communication with an ophthalmologist or oncologist can then play a key role in impacting QoL. In this prospective study co-designed with patient’s partners and using a mixed-method approach, 250 patients at high versus low risk of metastatic recurrence are recruited in a national UM reference centre in France. At T1, after the 6-months post-treatment surveillance visit, dyads of clinicians and eligible patients complete a questionnaire to assess their respective experience of the communication during that consultation. Patients also complete questionnaires assessing their health literacy, information preference, and satisfaction with the information received (EORTC QLQ-INFO25), genomic testing knowledge, genomic test result receipt, satisfaction with medical care (EORTC PATSAT-C33), perceived recurrence risk, anxiety and depression (HADS), fear of cancer recurrence (FCRI) and quality of life (EORTC QLQ-C30 and QLQ-OPT30). At 12-months post-treatment (T2), patients complete again the HADS, FCRI, EORTC QLQ-C30 and QLQ-OPT30. Multilevel analyses will assess the effect of satisfaction with the information received on FCR and QoL accounting for the clinicians’ and patients’ characteristics. In-depth interviews planned sequentially with ≈25 patients will deepen understanding of patients’ care experience. As information on prognosis based on medical parameters becomes widely integrated into oncology practice, this study will highlight UM survivors’ information expectations and satisfaction with communication, and its effect on FCR and QoL. Culturally adapted recommendations for doctor-patient communication will be provided for contexts of oncology surveillance involving poor prognosis in cases of recurrence. NCT06073548 (October 4, 2023).

23 September 2026 in Future Oncology
Verified
Journal Article
Closed access
ABAnne Bredart
Anne Bredart
PBPauline Bugeon
Pauline Bugeon
CBCéline Bodelet
Céline Bodelet
MDMorgan Dondin
Morgan Dondin
AMAnita Müller
Anita Müller
SDSylvie Dolbeault
Sylvie Dolbeault
Imagine you are a patient with a triple-negative breast cancer. You have been informed that you present a higher risk of relapse compared to patients with another type of breast cancer, and because...

24 July 2025 in Éthique & Santé
Verified
Journal Article
Closed access
AMAnita Müller
Anita Müller
CMCharles Martin-Krumm
Charles Martin-Krumm
LKL. Kern
L. Kern
SBS. Barbot
S. Barbot
SDS. Dolbeault
S. Dolbeault
ABAnne Bredart
Anne Bredart

6 November 2025 in Bulletin du Cancer
Verified
Journal Article
Open access
AMAnita Müller
Anita Müller
PVPauline Vaflard
Pauline Vaflard
MMMarie-France Mamzer
Marie-France Mamzer
NCNathalie Cassoux
Nathalie Cassoux
ABAnne Bredart
Anne Bredart
SDSylvie Dolbeault
Sylvie Dolbeault
Uveal melanomas (UM) are rare intraocular tumours. A third of these patients develop metastases, mostly hepatic ones. Patients can be given prognosis estimations thanks to clinical and genomic criteria. Nonetheless, in the context of UM, the transmission of information pinpoints numerous ethical concerns for physicians, due to the complex nature of its therapeutic care. This study aims to explore the modalities of physician-patient communication, particularly regarding the transmission of prognostic information to patients, and to understand physicians' experience. Semi-directive interviews have been conducted with two oncologists and four onco-ophthalmologists specialised in treating UM treatment. Interviews were transcribed, anonymised and we performed a thematical analysis. After completion of the interviews' analysis, five main themes have emerged: the lack of questioning from patients, the communication about the recurrence risk, the uncertainty and the role of hope and the emotional impact on physicians. The communication of prognosis information highlights many ethical stakes. In the context of UM, physicians emphasize the importance of providing information tailored to each patient's needs, at the right time, while maintaining hope and avoiding providing overly direct information to everyone.

20 October 2026 in Cancers
Verified
Journal Article
Open access
PDF file
AMAnita Müller
Anita Müller
SBSelma Barbot
Selma Barbot
MDMorgan Dondin
Morgan Dondin
CPClotilde Potez
Clotilde Potez
SDSylvie Dolbeault
Sylvie Dolbeault
BHBernhard Holzner
Bernhard Holzner
Background/Objectives: In recent years, the number of cancer survivors has increased. Psychological difficulties or disorders are frequent during survivorship (e.g., fear of cancer recurrence, anxiety, depression, and insomnia). Various interventions have been developed to address survivors’ specific psychosocial needs. This rapid scoping review aimed to define the interventions that have been developed for adult cancer survivors by describing (1) the type of intervention, (2) their measured psychosocial outcome variables, and (3) participants’ main characteristics. Methods: PubMed was searched for articles published between 2020 and 2025. The search strategy combined terms related to cancer survivorship, psychosocial outcomes, and interventions. Titles and abstracts were screened, and data were extracted using a structured form specifying study type, population, intervention, and outcome characteristics. PRISMA-ScR guidelines were followed. Results: Out of 1743 screened studies, 80 were included (67 studies, 13 systematic reviews/meta-analyses), representing approximately 7880 cancer survivors (from the n = 67). Nearly 45% of included studies were conducted in the United States, and most interventions were developed for breast cancer survivors (38.8%) or included a majority of female participants. Physical activity (22.39%), psychoeducation (17.9%), and cognitive behavioural therapy (16.4%) were the most common intervention types. About a third incorporated eHealth or telehealth. Two-thirds of studies (65.7%) reported predominantly positive effects on psychosocial outcomes. Few interventions included cultural adaptations and targeted minority or socioeconomically disadvantaged populations. Conclusions: Most interventions for cancer survivors targeted breast cancer, female survivors in high-income countries. Developing and implementing culturally adapted and cost-efficient interventions, particularly for underrepresented survivor groups, remains a priority for future research and implementation.